Group One Trading, L.P. Kinnate Biopharma Inc. Transaction History

Group One Trading, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$2.24 - $2.66 $469,154 - $557,121	-209,444 Reduced 37.16%	354,121 $941,000
Q4 2023 Feb 14, 2024	BUY	$1.07 - $2.5 $602,693 - $1.41 Million	563,265 Added 187755.0%	563,565 $1.34 Million
Q2 2023 Aug 09, 2023	BUY	$2.33 - $6.84 $699 - $2,052	300 New	300 $0

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.